Pregnant women whose depression is not adequately treated may make decisions that can harm the baby such as not eating well or using alcohol, or continuing to take SSRIs - a group of antidepressants that include Paxil and Zoloft.
In July 2006, The FDA warned about the correlation between SSRIs and birth defects, particularly persistent pulmonary hypertension (PPHN) in newborns. Two years earlier, in August 2004, Health Canada warned that taking Paxil during late pregnancy could put babies at risk: international and Canadian reports indicated that some newborns developed complications at birth requiring prolonged hospitalization, breathing support and tube feeding.
It wasn't until December 2006, that the American College of Obstetricians and Gynecologists published in its journal, Obstetrics & Gynecology, a warning to women who are pregnant, or plan to be, to avoid taking Paxil because of a risk of birth defects.
There are, of course, other and safer drugs to alleviate depression, such as the tricyclic antidepressants. Still, SSRIs continue to be the big sellers, even though two recent studies raised concerns about the safety of SSRIs during pregnancy.
READ MORE LEGAL NEWS
Even now, with this evidence, pregnant women are advised not to discontinue use of SSRIs before speaking to a doctor. But for some babies, their mother's visit to the doctor to discuss whether or not to continue taking Paxil or Zoloft or any other SSRI may come too late.